@article{devos_d_targeting_2014,
title = {Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease},
volume = {21},
issn = {1523-0864},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24251381},
DOI = {10.1089/ars.2013.5593},
Language = {English},
Journal = {Antioxid. Redox Signal.},
author = {{Devos D} and {Moreau C} and {Devedjian JC} and {Kluza J} and {Petrault M} and {Laloux C} and {Jonneaux A} and {Ryckewaert G} and {Garcon G} and {Rouaix N} and {Duhamel A} and {Jissendi P} and {Dujardin K} and {Auger F} and {Ravasi L} and {Hopes L} and {Grolez G} and {Firdaus W} and {Sablonniere B} and {Strubi-Vuillaume I} and {Zahr N} and {Destee A} and {Corvol JC} and {Poltl D} and {Leist M} and {Rose C} and {Defebvre L} and {Marchetti P} and {Cabantchik ZI} and {Bordet R}},
year = {2014},
keywords = {Animals, Cell Line, Combined Modality Therapy, Disease Models, Animal, Double-Blind Method, Humans, Iron/metabolism*, Iron Chelating Agents/administration & dosage, Iron Chelating Agents/therapeutic use*, Male, Mice, Mice, Inbred C57BL, Motor Activity/drug effects, Oxidative Stress/drug effects, Parkinson Disease/drug therapy*, Parkinson Disease/metabolism*, Pilot Projects, Pyridones/administration & dosage, Pyridones/pharmacology, Pyridones/therapeutic use*},
pages = {195-210}
}

{"_id":"dS2NMwDLeYYfiQiEd","bibbaseid":"devosd-moreauc-devedjianjc-kluzaj-petraultm-lalouxc-jonneauxa-ryckewaertg-etal-targetingchelatableironasatherapeuticmodalityinparkinsonsdisease-2014","authorIDs":[],"author_short":["Devos D","Moreau C","Devedjian JC","Kluza J","Petrault M","Laloux C","Jonneaux A","Ryckewaert G","Garcon G","Rouaix N","Duhamel A","Jissendi P","Dujardin K","Auger F","Ravasi L","Hopes L","Grolez G","Firdaus W","Sablonniere B","Strubi-Vuillaume I","Zahr N","Destee A","Corvol JC","Poltl D","Leist M","Rose C","Defebvre L","Marchetti P","Cabantchik ZI","Bordet R"],"bibdata":{"bibtype":"article","type":"article","title":"Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease","volume":"21","issn":"1523-0864","url":"http://www.ncbi.nlm.nih.gov/pubmed/24251381","doi":"10.1089/ars.2013.5593","language":"English","journal":"Antioxid. Redox Signal.","author":[{"firstnames":[],"propositions":[],"lastnames":["Devos D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Moreau C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Devedjian JC"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kluza J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Petrault M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Laloux C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Jonneaux A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ryckewaert G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Garcon G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Rouaix N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Jissendi P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dujardin K"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Auger F"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ravasi L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Hopes L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Grolez G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Firdaus W"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Sablonniere B"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Strubi-Vuillaume I"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Zahr N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Destee A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Corvol JC"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Poltl D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Leist M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Rose C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Defebvre L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Marchetti P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cabantchik ZI"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bordet R"],"suffixes":[]}],"year":"2014","keywords":"Animals, Cell Line, Combined Modality Therapy, Disease Models, Animal, Double-Blind Method, Humans, Iron/metabolism*, Iron Chelating Agents/administration & dosage, Iron Chelating Agents/therapeutic use*, Male, Mice, Mice, Inbred C57BL, Motor Activity/drug effects, Oxidative Stress/drug effects, Parkinson Disease/drug therapy*, Parkinson Disease/metabolism*, Pilot Projects, Pyridones/administration & dosage, Pyridones/pharmacology, Pyridones/therapeutic use*","pages":"195-210","bibtex":"@article{devos_d_targeting_2014,\r\ntitle = {Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease},\r\nvolume = {21},\r\nissn = {1523-0864},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/24251381},\r\nDOI = {10.1089/ars.2013.5593},\r\nLanguage = {English},\r\nJournal = {Antioxid. Redox Signal.},\r\nauthor = {{Devos D} and {Moreau C} and {Devedjian JC} and {Kluza J} and {Petrault M} and {Laloux C} and {Jonneaux A} and {Ryckewaert G} and {Garcon G} and {Rouaix N} and {Duhamel A} and {Jissendi P} and {Dujardin K} and {Auger F} and {Ravasi L} and {Hopes L} and {Grolez G} and {Firdaus W} and {Sablonniere B} and {Strubi-Vuillaume I} and {Zahr N} and {Destee A} and {Corvol JC} and {Poltl D} and {Leist M} and {Rose C} and {Defebvre L} and {Marchetti P} and {Cabantchik ZI} and {Bordet R}},\r\nyear = {2014},\r\nkeywords = {Animals, Cell Line, Combined Modality Therapy, Disease Models, Animal, Double-Blind Method, Humans, Iron/metabolism*, Iron Chelating Agents/administration & dosage, Iron Chelating Agents/therapeutic use*, Male, Mice, Mice, Inbred C57BL, Motor Activity/drug effects, Oxidative Stress/drug effects, Parkinson Disease/drug therapy*, Parkinson Disease/metabolism*, Pilot Projects, Pyridones/administration & dosage, Pyridones/pharmacology, Pyridones/therapeutic use*},\r\npages = {195-210}\r\n}\r\n\r\n","author_short":["Devos D","Moreau C","Devedjian JC","Kluza J","Petrault M","Laloux C","Jonneaux A","Ryckewaert G","Garcon G","Rouaix N","Duhamel A","Jissendi P","Dujardin K","Auger F","Ravasi L","Hopes L","Grolez G","Firdaus W","Sablonniere B","Strubi-Vuillaume I","Zahr N","Destee A","Corvol JC","Poltl D","Leist M","Rose C","Defebvre L","Marchetti P","Cabantchik ZI","Bordet R"],"key":"devos_d_targeting_2014","id":"devos_d_targeting_2014","bibbaseid":"devosd-moreauc-devedjianjc-kluzaj-petraultm-lalouxc-jonneauxa-ryckewaertg-etal-targetingchelatableironasatherapeuticmodalityinparkinsonsdisease-2014","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/24251381"},"keyword":["Animals","Cell Line","Combined Modality Therapy","Disease Models","Animal","Double-Blind Method","Humans","Iron/metabolism*","Iron Chelating Agents/administration & dosage","Iron Chelating Agents/therapeutic use*","Male","Mice","Mice","Inbred C57BL","Motor Activity/drug effects","Oxidative Stress/drug effects","Parkinson Disease/drug therapy*","Parkinson Disease/metabolism*","Pilot Projects","Pyridones/administration & dosage","Pyridones/pharmacology","Pyridones/therapeutic use*"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.056Z","downloads":0,"keywords":["animals","cell line","combined modality therapy","disease models","animal","double-blind method","humans","iron/metabolism*","iron chelating agents/administration & dosage","iron chelating agents/therapeutic use*","male","mice","mice","inbred c57bl","motor activity/drug effects","oxidative stress/drug effects","parkinson disease/drug therapy*","parkinson disease/metabolism*","pilot projects","pyridones/administration & dosage","pyridones/pharmacology","pyridones/therapeutic use*"],"search_terms":["targeting","chelatable","iron","therapeutic","modality","parkinson","disease","devos d","moreau c","devedjian jc","kluza j","petrault m","laloux c","jonneaux a","ryckewaert g","garcon g","rouaix n","duhamel a","jissendi p","dujardin k","auger f","ravasi l","hopes l","grolez g","firdaus w","sablonniere b","strubi-vuillaume i","zahr n","destee a","corvol jc","poltl d","leist m","rose c","defebvre l","marchetti p","cabantchik zi","bordet r"],"title":"Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease","year":2014,"dataSources":["Tt6zYqvN5kE3wbwiR"]}